{"id":"NCT01964326","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","briefTitle":"Actual Use Trial of Atorvastatin Calcium 10 mg","officialTitle":"A Multicenter, Actual Use Trial In A Simulated Over-the-counter Environment Of Atorvastatin Calcium 10 Mg","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-10","primaryCompletion":"2014-12","completion":"2014-12","firstPosted":"2013-10-17","resultsPosted":"2016-01-27","lastUpdate":"2021-02-21"},"enrollment":1311,"design":{"allocation":"NA","model":null,"masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hypercholesterolemia"],"interventions":[{"type":"DRUG","name":"Atorvastatin calcium 10 mg","otherNames":[]}],"arms":[{"label":"Atorvastatin calcium 10 mg","type":"EXPERIMENTAL"}],"summary":"The purpose of this actual use study is to simulate the over the counter use of atorvastatin calcium 10 mg.","primaryOutcome":{"measure":"Percentage of Participants Who Complied With the Direction to Check Their Low-density Lipoprotein Cholesterol (LDL-C) Level","timeFrame":"Day 1 up to Week 26","effectByArm":[{"arm":"Atorvastatin","deltaMin":49.7,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":37,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A2581189&StudyName=Actual%20Use%20Trial%20of%20Atorvastatin%20Calcium%2010%20mg%20"]},"adverseEventsSummary":{"seriousAny":{"events":53,"n":1234},"commonTop":["Myalgia","Nasopharyngitis","Diarrhoea","Headache","Nausea"]}}